Structures by: Lahmidi S.
Total: 18
1-(3-Hydroxypropyl)-3-phenylquinoxalin-2(1<i>H</i>)-one
C17H16N2O2
IUCrData (2018) 3, 11 x181633
a=8.1914(14)Å b=9.5151(16)Å c=17.781(3)Å
α=90° β=94.880(2)° γ=90°
2-Amino-5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7(4<i>H</i>)-one
C6H7N5O
IUCrData (2018) 3, 11 x181500
a=6.5921(14)Å b=8.3935(18)Å c=13.185(3)Å
α=92.023(3)° β=98.309(3)° γ=99.741(3)°
1-Methyl-4-phenyl-3-[4-(trifluoromethyl)phenyl]-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine
C19H13F3N4
IUCrData (2018) 3, 6 x180875
a=15.0553(10)Å b=15.7338(12)Å c=6.9701(5)Å
α=90° β=99.540(4)° γ=90°
Ethyl 2-(5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7-yl)pent-4-enoate
C13H16N4O2
IUCrData (2018) 3, 9 x181280
a=9.069(5)Å b=13.319(7)Å c=11.851(7)Å
α=90° β=112.161(7)° γ=90°
1-Methyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4(5<i>H</i>)-one
C6H6N4O
IUCrData (2018) 3, 3 x180483
a=3.8342(2)Å b=5.5701(3)Å c=15.0346(9)Å
α=93.396(4)° β=92.812(4)° γ=92.361(4)°
1-Benzyl-4-phenyl-1<i>H</i>-1,5-benzodiazepin-2(3<i>H</i>)-one
C22H18N2O
IUCrData (2016) 1, 12 x161988
a=14.6973(7)Å b=5.9179(3)Å c=19.8537(9)Å
α=90° β=93.4610(10)° γ=90°
Ethyl (2<i>E</i>)-3-dimethylamino-2-(5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7-yl)prop-2-enoate
C13H17N5O2
IUCrData (2016) 1, 12 x161946
a=7.1482(15)Å b=10.306(2)Å c=19.705(4)Å
α=90° β=99.711(3)° γ=90°
3,5-Diamino-4<i>H</i>-1,2,4-triazol-1-ium 4-nitrobenzoate dihydrate
C2H6N5,C7H4NO4,2(H2O)
IUCrData (2017) 2, 2 x170159
a=7.2050(2)Å b=19.8831(6)Å c=9.7676(3)Å
α=90° β=105.6910(10)° γ=90°
2-(2-Amino-5-methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidin-7-yl)acetohydrazide monohydrate
C8H11N7O,H2O
IUCrData (2016) 1, 6 x160870
a=7.2648(3)Å b=8.7228(4)Å c=8.9297(4)Å
α=82.834(2)° β=71.465(2)° γ=85.4780(10)°
(3<i>S</i>)-3,8-Dibromo-4-phenyl-2,3-dihydro-1<i>H</i>-1,5-benzodiazapin-2-one
C15H10Br2N2O
IUCrData (2017) 2, 3 x170389
a=7.8931(8)Å b=9.9295(10)Å c=10.2411(11)Å
α=101.7510(10)° β=105.968(2)° γ=109.4820(10)°
3-Acetyl-2-methyl-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-4-one
C11H10N2O2
IUCrData (2017) 2, 7 x170991
a=3.7716(6)Å b=10.3959(15)Å c=12.3280(18)Å
α=78.017(2)° β=83.431(2)° γ=81.266(2)°
(2<i>Z</i>)-2-Benzylidene-4-octadecyl-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C33H47NOS
IUCrData (2017) 2, 5 x170695
a=33.8411(7)Å b=4.71060(10)Å c=18.0987(4)Å
α=90° β=90.4700(10)° γ=90°
5-Nitro-1-(prop-2-en-1-yl)-1<i>H</i>-indazole
C10H9N3O2
IUCrData (2017) 2, 7 x171091
a=6.9549(5)Å b=11.6778(9)Å c=12.2165(9)Å
α=90° β=90° γ=90°
2-Methyl-3-(3-methylisoxazol-5-yl)-4-oxo-4<i>H</i>-pyrido[1,2-<i>a</i>]pyrimidin-1-ium chloride
C13H12N3O2,Cl
IUCrData (2016) 1, 12 x161978
a=6.2796(12)Å b=9.6912(18)Å c=21.152(4)Å
α=90° β=95.294(3)° γ=90°
5-[(5-Nitro-1<i>H</i>-indazol-1-yl)methyl]-3-phenyl-4,5-dihydroisoxazole
C17H14N4O3
Acta Crystallographica Section E (2019) 75, 1 71-74
a=7.8595(4)Å b=11.8831(7)Å c=15.5716(9)Å
α=90° β=101.8530(10)° γ=90°
5-Methyl-1,2,4-triazolo[1,5-<i>a</i>]pyrimidine
C6H6N4
Acta Crystallographica Section E (2018) 74, 12 1833-1837
a=3.7910(2)Å b=18.0092(10)Å c=9.0069(5)Å
α=90° β=101.704(2)° γ=90°
3-(4-Methoxyphenyl)-1-methyl-4-phenyl-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine
C19H16N4O
Acta Crystallographica Section E (2019) 75, 5 638-641
a=6.5227(3)Å b=7.8979(4)Å c=30.7774(15)Å
α=90° β=95.389(2)° γ=90°
(<i>Z</i>)-7,8-Dichloro-4-(2-oxopropylidene)-4,5-dihydro-1<i>H</i>-1,5-benzodiazepin-2(3<i>H</i>)-one
C12H10Cl2N2O2
Acta Crystallographica Section E (2015) 71, 12 o1059-o1060
a=7.6789(4)Å b=13.2199(6)Å c=12.4129(7)Å
α=90° β=102.561(3)° γ=90°